- Magnetic resonance imaging following treatment of advanced hepatocellular carcinoma with sorafenib
-
Choi JI, Imagawa DK, Bhosale P, Bhargava P, Tirkes T, Seery TE, Lall C
- KMID: 1788573
- Clin Mol Hepatol.
- 2014 Jun;20(2):218-222.
- doi: 10.3350/cmh.2014.20.2.218
Hepatocellular carcinomas are highly vascular tumors, showing progressive hypervascularity by the process of neoangiogenesis. Tumor angiogenesis is critical for tumor growth as well as metastatic spread therefore, imaging and quantification... -
- CITED
-
- Close
- SHARE
-
- Close
- Challenge and Hope in Radiotherapy of Hepatocellular Carcinoma
-
Seong J
- KMID: 1103811
- Yonsei Med J.
- 2009 Oct;50(5):601-612.
- doi: 10.3349/ymj.2009.50.5.601
Hepatocellular carcinoma (HCC) is one of the most critical global health issues. With frequent association of viral liver disease, HCC is highly complex, harboring both cancer and chronic liver disease.... -
- CITED
-
- Close
- SHARE
-
- Close
- Identification of Novel Methylation Markers in Hepatocellular Carcinoma using a Methylation Array
-
Shin SH, Kim BH, Jang JJ, Suh KS, Kang GH
- KMID: 1714035
- J Korean Med Sci.
- 2010 Aug;25(8):1152-1159.
- doi: 10.3346/jkms.2010.25.8.1152
Promoter CpG island hypermethylation has become recognized as an important mechanism for inactivating tumor suppressor genes or tumor-related genes in human cancers of various tissues. Gene inactivation in association with... -
- CITED
-
- Close
- SHARE
-
- Close
- Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma
-
Ji SK, Park NH, Choi HM, Kim YW, Lee SH, Lee KH, Ahn SY, Lee SU, Han BH, Park BC
- KMID: 1038464
- Korean J Intern Med.
- 1996 Jan;11(1):58-68.
To evaluate the clinical efficacy of alpha-interferon(IFN-alpha) plus cis-platinum in hepatocellular carcinoma(HCC). 56 inoperable patients with HCC were divided into IFN-alpha plus cis-platinum treated group (n = 30) and no... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
-
Cha J, Seong J, Lee IJ, Kim JW, Han KH
- KMID: 1793165
- Yonsei Med J.
- 2013 Sep;54(5):1178-1185.
- doi: 10.3349/ymj.2013.54.5.1178
PURPOSE: Sorafenib is an effective systemic agent for advanced hepatocellular carcinoma. To increase its efficacy, we evaluated the feasibility and benefit of sorafenib combined with radiotherapy. MATERIALS AND METHODS: From July... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience
-
Lee SS, Shin HS, Kim HJ, Lee SJ, Lee HS, Hyun KH, Kim YH, Kwon BW, Han JH, Choi H, Kim BH, Lee JH, Kang HY, Shin HD, Song IH
- KMID: 1372651
- Korean J Hepatol.
- 2012 Mar;18(1):48-55.
- doi: 10.3350/kjhep.2012.18.1.48
BACKGROUND/AIMS: Hepatocellular carcinoma (HCC), which is the third most common cancer in Korea, has a very poor prognosis. However, only a few studies have performed a comprehensive survival-related analysis in... -
- CITED
-
- Close
- SHARE
-
- Close
- A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma
-
Kim HY, Kim JD, Bae SH, Park JY, Han KH, Woo HY, Choi JY, Yoon SK, Jang BK, Hwang JS, Kim SG, Kim YS, Seo YS, Yim HJ, Um SH, Korean Liver Cancer Study Group
- KMID: 1117691
- Korean J Hepatol.
- 2010 Dec;16(4):355-361.
- doi: 10.3350/kjhep.2010.16.4.355
BACKGROUND/AIMS: Transarterial chemoembolization (TACE) has long been used as a palliative therapy for unresectable hepatocellular carcinoma (HCC). High-dose hepatic arterial infusion chemotherapy (HAIC) has showed favorable outcomes in patients with... -
- CITED
-
- Close
- SHARE
-
- Close
